Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo M Croce

Showing results (71-80 of 599) with videos related to

Pageof 60
Sort By:
Nature Reviews. Drug Discovery|October 2, 2010
Targeting microRNAs in cancer: rationale, strategies and challengesRamiro Garzon, Guido Marcucci, Carlo M Croce
Idrugs : the Investigational Drugs Journal|December 15, 2010
MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugsS Patrick Nana-Sinkam, Carlo M Croce
Cancer Genomics & Proteomics|August 7, 2009
Pathogenetic and clinical relevance of microRNAs in colorectal cancerNicola Valeri, Carlo M Croce, Muller Fabbri
Genome Biology|October 16, 2014
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical useS Patrick Nana-Sinkam, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2019
Experimental Validation of MicroRNA Targets: Luciferase Reporter AssayLuisa Tomasello, Landon Cluts, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2019
Experimental Validation of MicroRNA Targets: Analysis of MicroRNA Targets Through Western BlottingLuisa Tomasello, Landon Cluts, Carlo M Croce
Annual Review of Medicine|July 28, 2009
MicroRNAs in CancerRamiro Garzon, George A Calin, Carlo M Croce
Immunological Reviews|April 5, 2013
MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Loss of ICOSL expression in the progression to cervical carcinomaGerard J Nuovo, Esmerina Tili, Carlo M Croce
Pageof 60

Showing results (71-80 of 599) with videos related to

Sort By:
Pageof 60
Nature Reviews. Drug Discovery|October 2, 2010
Targeting microRNAs in cancer: rationale, strategies and challengesRamiro Garzon, Guido Marcucci, Carlo M Croce
Idrugs : the Investigational Drugs Journal|December 15, 2010
MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugsS Patrick Nana-Sinkam, Carlo M Croce
Cancer Genomics & Proteomics|August 7, 2009
Pathogenetic and clinical relevance of microRNAs in colorectal cancerNicola Valeri, Carlo M Croce, Muller Fabbri
Genome Biology|October 16, 2014
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical useS Patrick Nana-Sinkam, Carlo M Croce
Journal of Cell Communication and Signaling|August 29, 2022
tRNA-derived fragments (tRFs) in cancerYuri Pekarsky, Veronica Balatti, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2019
Experimental Validation of MicroRNA Targets: Luciferase Reporter AssayLuisa Tomasello, Landon Cluts, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|April 10, 2019
Experimental Validation of MicroRNA Targets: Analysis of MicroRNA Targets Through Western BlottingLuisa Tomasello, Landon Cluts, Carlo M Croce
Annual Review of Medicine|July 28, 2009
MicroRNAs in CancerRamiro Garzon, George A Calin, Carlo M Croce
Immunological Reviews|April 5, 2013
MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Loss of ICOSL expression in the progression to cervical carcinomaGerard J Nuovo, Esmerina Tili, Carlo M Croce
Pageof 60